Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ENGNenGene Therapeutics Inc.

Nasdaq · CIK 0001980845
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1031
XBRL facts209

Identity from submissions API

NameenGene Therapeutics Inc.
CIK0001980845
TickersENGN, ENGNW
ExchangesNasdaq, Nasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1031
State of incorporationZ4 Canada (Federal Level)
Phone(514) 332-4888
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • enGene Holdings Inc. (2023-06-14T04:00:00.000Z → 2026-03-09T04:00:00.000Z)
Business address
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
Quebec, Canada
A8
Mailing address
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
Quebec, Canada
A8

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

272 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-463806 005-94211 261562643 34 11646
2026-11-13 4 xslF345X06/ownership.xml 0001552781-26-000553 5972
2026-11-13 3 xslF345X06/ownership.xml 0001552781-26-000552 11703
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001580642-26-007717 005-94211 261553449 34 12559
2026-11-12 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-456703 001-41854 261542764 34 37475612 1 1
2026-09-24 4 xslF345X06/ownership.xml 0001552781-26-000501 4993
2026-09-08 10-Q 10-Q 0001193125-26-384383 001-41854 261363394 34 13637239 1 1
2026-09-08 8-K 8-K 2.02,9.01 0001193125-26-384380 001-41854 261363384 34 419410 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352637 005-94211 261283729 34 11914
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000931 005-94211 261283140 34 17145
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003477 005-94211 261276361 34 11508
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002005369-26-000051 005-94211 261271330 34 18592
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-032512 005-94211 261268039 34 8142
2026-08-11 8-K 8-K 8.01,9.01 0001193125-26-344559 001-41854 261263073 34 11371023 1 1
2026-07-22 3 xslF345X06/form3.xml 0000929638-26-002667 9715
2026-07-22 3 xslF345X06/form3.xml 0000929638-26-002666 13419
2026-07-22 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001636587-26-000058 005-94211 261191966 34 12654
2026-07-17 8-K 8-K 7.01,9.01 0001193125-26-307795 001-41854 261183759 34 16573086 1 1
2026-07-16 8-K 8-K 5.02,7.01,9.01 0001193125-26-305418 001-41854 261178725 34 234023 1 1
2026-06-18 8-K/A 8-K/A 2.05,5.02 0001193125-26-275815 001-41854 261102533 34 202999 1 1
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002263 5471
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002262 5467
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002261 5500
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002260 8215
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002259 5435
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002258 5504
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002257 5502
2026-06-17 4 xslF345X06/form4.xml 0000929638-26-002256 5505
2026-06-15 10-Q 10-Q 0001193125-26-270386 001-41854 261089205 34 11789244 1 1
2026-06-15 8-K 8-K 2.02,2.05,5.02,7.01,8.01,9.01 0001193125-26-270384 001-41854 261089199 34 451730 1 1
2026-06-10 8-K 8-K 5.07,9.01 0001193125-26-265830 001-41854 261079743 34 217114 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002215 005-94211 26985151 34 9770
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001373604-26-000042 005-94211 26976489 34 6593
2026-05-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001373604-26-000041 005-94211 26975477 34 6552
2026-05-08 ARS ARS 0001140361-26-020034 001-41854 26958366 34 15790309
2026-05-08 DEF 14A DEF 14A 0001140361-26-020024 001-41854 26958270 34 2646005 1 1
2026-05-07 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-26-210316 001-41854 26950832 34 2425031 1 1
2026-05-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002005369-26-000035 005-94211 26941327 34 18592
2026-04-09 8-K 8-K 5.03,7.01,9.01 0001193125-26-149597 001-41854 26851539 34 1291049 1 1
2026-03-09 S-8 S-8 0001193125-26-098008 333-294136 26733924 33 428787 1 1
2026-03-09 424B5 424B5 0001193125-26-097563 333-293597 26733180 33 615504
2026-03-09 8-K 8-K 1.01,1.02,9.01 0001193125-26-097546 001-41854 26733170 34 735439 1 1
2026-03-09 10-Q 10-Q 0001193125-26-097541 001-41854 26733163 34 10332228 1 1
2026-03-09 8-K 8-K 2.02,9.01 0001193125-26-097534 001-41854 26733154 34 356265 1 1
2026-03-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000700 333-293597 26710922 33 1746
2026-02-26 CORRESP filename1.htm 0001193125-26-074564 13750
2026-02-25 UPLOAD filename1.pdf 0000000000-26-001921 333-293597 40053
2026-02-19 S-3 S-3 0001193125-26-059479 333-293597 26654825 33 2084292 1 1
2026-02-19 10-K/A 10-K/A 0001193125-26-059409 001-41854 26654587 34 1289752 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001738048-26-000020 005-94211 26644104 34 17752
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001032 005-94211 26640016 34 10679
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001907884-26-000003 005-94211 26638940 34 9378
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000484 5040
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000483 5051
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000482 5054
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000481 5023
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000480 5173
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000479 5069
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000478 5065
2026-02-03 4 xslF345X05/form4.xml 0000929638-26-000477 5102
2026-01-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002005369-26-000002 005-94211 26564201 34 25004
2026-01-21 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-26-017945 001-41854 26547830 34 1489530 1 1
2026-01-21 8-K 8-K 7.01,9.01 0001193125-26-017226 001-41854 26544806 34 250238 1 1
2025-12-22 10-K 10-K 0001193125-25-328743 001-41854 251592563 34 17113397 1 1
2025-12-22 8-K 8-K 2.02,9.01 0001193125-25-328706 001-41854 251592433 34 359838 1 1
2025-11-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005207 005-94211 251494498 34 11151
2025-11-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-286126 005-94211 251494433 34 176078
2025-11-14 8-K 8-K 1.01,7.01,9.01 0001193125-25-283182 001-41854 251487451 34 729397 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004824 005-94211 251481371 34 11342
2025-11-14 424B5 424B5 0001193125-25-281504 333-283201 251481115 33 643920
2025-11-12 424B5 424B5 0001193125-25-277833 333-283201 251473831 33 603143
2025-11-12 8-K 8-K 7.01,8.01,9.01 0001193125-25-275722 001-41854 251468392 34 5844894 1 1
2025-10-02 8-K 8-K 5.02 0001193125-25-228351 001-41854 251369266 34 183968 1 1
2025-10-02 8-K/A 8-K/A 5.02 0001193125-25-228331 001-41854 251369189 34 187901 1 1
2025-10-01 4 xslF345X05/form4.xml 0000929638-25-003710 5444
2025-10-01 3 xslF345X02/form3.xml 0000929638-25-003709 8991
2025-09-30 8-K 8-K 7.01,9.01 0001193125-25-224053 001-41854 251358163 34 391500 1 1
2025-09-11 S-8 S-8 0001193125-25-201369 333-290197 251309043 33 260944 1 1
2025-09-11 10-Q 10-Q 0000950170-25-114224 001-41854 251308655 34 10414552 1 1
2025-09-11 8-K 8-K 2.02,9.01 0000950170-25-114220 001-41854 251308610 34 394992 1 1
2025-09-03 8-K 8-K 7.01,8.01,9.01 0000950170-25-112674 001-41854 251287766 34 1911220 1 1
2025-07-14 4 xslF345X05/form4.xml 0000929638-25-002586 5186
2025-07-14 3 xslF345X02/form3.xml 0000929638-25-002585 10977
2025-07-10 4 xslF345X05/form4.xml 0000929638-25-002558 5062
2025-07-10 4 xslF345X05/form4.xml 0000929638-25-002557 5091
2025-07-10 4 xslF345X05/form4.xml 0000929638-25-002556 5079
2025-07-10 4 xslF345X05/form4.xml 0000929638-25-002554 5100
2025-07-08 3 xslF345X02/form3.xml 0000929638-25-002534 8368
2025-07-08 3 xslF345X02/form3.xml 0000929638-25-002532 8965
2025-07-08 3 xslF345X02/form3.xml 0000929638-25-002530 8354
2025-07-08 3 xslF345X02/form3.xml 0000929638-25-002528 10266
2025-07-08 8-K a8k.htm 5.02,7.01,9.01 0000929638-25-002520 001-41854 251109556 34 240678 1 1
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002253 5110
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002252 5393
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002251 5076
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002250 5041
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002249 5105
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002248 5803
2025-06-16 4 xslF345X05/form4.xml 0000929638-25-002247 5072
2025-06-12 10-Q 10-Q 0000950170-25-085143 001-41854 251041710 34 10356509 1 1
2025-06-12 8-K 8-K 2.02,9.01 0000950170-25-085138 001-41854 251041705 34 382433 1 1
2025-06-10 8-K a8k.htm 5.02,5.07,9.01 0000929638-25-002215 001-41854 251038124 34 312112 1 1
2025-06-09 8-K 8-K 1.01,2.03,9.01 0000950170-25-083444 001-41854 251032837 34 2476267 1 1
2025-06-04 8-K a8k.htm 5.02,7.01,9.01 0000929638-25-002133 001-41854 251022004 34 214748 1 1
2025-05-29 3 xslF345X02/form3.xml 0000929638-25-002110 7533
2025-05-09 ARS ARS 0001140361-25-018160 001-41854 25930473 34 2215623
2025-05-09 DEF 14A 2025 PROXY STATEMENTS 0001140361-25-018155 001-41854 25930321 34 1630463 1 1
2025-03-10 S-8 S-8 0000950170-25-036346 333-285679 25724104 33 254340
2025-03-10 10-Q 10-Q 0000950170-25-036281 001-41854 25723784 34 9020848 1 1
2025-03-10 8-K 8-K 2.02,9.01 0000950170-25-036264 001-41854 25723715 34 338770 1 1
2025-02-20 10-K/A 10-K/A 0000950170-25-024221 001-41854 25646052 34 1261974 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004253 005-94211 25631611 34 24559
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-001725 005-94211 25630939 34 9265
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013919 005-94211 25626790 34 10661
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000882 005-94211 25623553 34 11297
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000870 005-94211 25612646 34 12441
2025-01-31 4 xslF345X05/form4.xml 0000929638-25-000481 5072
2025-01-31 4 xslF345X05/form4.xml 0000929638-25-000480 5061
2025-01-31 4 xslF345X05/form4.xml 0000929638-25-000479 5058
2025-01-31 4 xslF345X05/form4.xml 0000929638-25-000478 5030
2025-01-31 4 xslF345X05/form4.xml 0000929638-25-000477 5047
2025-01-31 4 xslF345X05/form4.xml 0000929638-25-000476 5180
2025-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000197 005-94211 25570294 34 24112
2025-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000196 005-94211 25570263 34 24560
2024-12-20 8-K 8-K 1.01,9.01 0000950170-24-138767 001-41854 241565081 34 642983 1 1
2024-12-20 424B5 424B5 0000950170-24-138766 333-283201 241565080 33 673043
2024-12-19 10-K 10-K 0000950170-24-138472 001-41854 241563649 34 17959743 1 1
2024-12-19 8-K 8-K 1.01,2.02,2.03,9.01 0000950170-24-138446 001-41854 241563365 34 324028 1 1
2024-11-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-21 16:00:00 9999999995-24-003546 333-283202 241486252 33 1754
2024-11-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-21 16:00:00 9999999995-24-003545 333-283201 241486251 33 1754
2024-11-21 424B3 424B3 0000950170-24-129754 333-283202 241485037 33 1006433
2024-11-21 424B3 424B3 0000950170-24-129751 333-283201 241485005 33 384726
2024-11-19 CORRESP filename1.htm 0000950170-24-128773 12722
2024-11-19 CORRESP filename1.htm 0000950170-24-128772 12722
2024-11-18 UPLOAD filename1.pdf 0000000000-24-012726 333-283201 40041
2024-11-18 UPLOAD filename1.pdf 0000000000-24-012725 333-283202 40043
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119321 005-94211 241464765 34 171621
2024-11-14 SC 13G/A SC 13G/A 0001140361-24-046976 005-94211 241464099 34 55521
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258017 005-94211 241457253 34 130740
2024-11-13 S-3 S-3 0000950170-24-126454 333-283202 241455371 33 2693727
2024-11-13 S-3 S-3 0000950170-24-126446 333-283201 241455311 33 3199514
2024-11-12 SC 13G ENGENE HOLDINGS INC. 0000902664-24-006393 005-94211 241444172 34 74484
2024-11-01 4 4 0000950170-24-120079 8845
2024-11-01 SC 13D/A SC 13D/A 0001193125-24-249815 005-94211 241419044 34 90851
2024-10-28 424B3 424B3 0001193125-24-244719 333-275700 241398478 33 3790087
2024-10-25 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-24-243481 001-41854 241394337 34 4036547 1 1
2024-10-22 4 xslF345X05/form4.xml 0000929638-24-003559 5137
2024-10-22 4 xslF345X05/form4.xml 0000929638-24-003557 5485
2024-10-22 3 xslF345X02/form3.xml 0000929638-24-003555 8827
2024-10-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950142-24-002608 005-94211 241382599 34 7788
2024-10-21 424B3 424B3 0000950170-24-115776 333-275700 241382150 33 77567
2024-10-21 8-K 8-K 5.02,7.01,8.01,9.01 0000950170-24-115767 001-41854 241382080 34 652594 1 1
2024-10-18 SC 13D/A SC 13D/A 0001193125-24-239641 005-94211 241380938 34 101528
2024-10-18 4 4 0000950170-24-115607 31606
2024-10-01 4 xslF345X05/form4.xml 0000929638-24-003358 4926
2024-09-26 424B3 424B3 0000950170-24-109468 333-275700 241326195 33 71334
2024-09-26 8-K 8-K 7.01,8.01,9.01 0000950170-24-109463 001-41854 241326149 34 3894521 1 1
2024-09-10 424B3 424B3 0000950170-24-105201 333-275700 241290631 33 1722325
2024-09-10 10-Q 10-Q 0000950170-24-105180 001-41854 241290520 34 10519637 1 1
2024-09-10 8-K 8-K 2.02,9.01 0000950170-24-105175 001-41854 241290469 34 330581 1 1
2024-09-05 8-K 8-K 7.01,9.01 0000950170-24-103727 001-41854 241279899 34 13165790 1 1
2024-07-25 4 xslF345X05/form4.xml 0000929638-24-002597 5116
2024-07-25 3 xslF345X02/form3.xml 0000929638-24-002596 8967
2024-07-24 4 xslF345X05/form4.xml 0000929638-24-002577 5552
2024-07-24 3 xslF345X02/form3.xml 0000929638-24-002575 7575
2024-07-24 424B3 424B3 0001193125-24-183294 333-275700 241136077 33 135955
2024-07-24 8-K 8-K 5.02,8.01,9.01 0001193125-24-183292 001-41854 241136075 34 331272 1 1
2024-06-18 4 xslF345X05/form4.xml 0000929638-24-002217 5113
2024-06-18 4 xslF345X05/form4.xml 0000929638-24-002216 5004
2024-06-18 4 xslF345X05/form4.xml 0000929638-24-002215 5040
2024-06-18 4 xslF345X05/form4.xml 0000929638-24-002214 5108
2024-06-18 4 xslF345X05/form4.xml 0000929638-24-002213 5075
2024-06-18 4 xslF345X05/form4.xml 0000929638-24-002212 5806
2024-06-14 424B3 424B3 0000950170-24-073412 333-275700 241043516 33 1574561
2024-06-14 10-Q 10-Q 0000950170-24-073330 001-41854 241043142 34 9841864 1 1
2024-06-14 8-K 8-K 2.02,7.01 0000950170-24-073326 001-41854 241043134 34 11000844 1 1
2024-05-29 4 xslF345X05/form4.xml 0000929638-24-002002 6658
2024-05-17 3 xslF345X02/form3.xml 0000929638-24-001843 7811
2024-05-17 3 xslF345X02/form3.xml 0000929638-24-001842 8100
2024-05-15 424B3 424B3 0000950170-24-060504 333-275700 24951187 33 300644
2024-05-15 8-K 8-K 5.02,5.07,9.01 0000950170-24-060449 001-41854 24950640 34 454346 1 1
2024-04-25 424B3 424B3 0000950170-24-048325 333-275700 24876480 33 105243
2024-04-22 4 OWNERSHIP DOCUMENT 0000950142-24-001171 7923
2024-04-18 ARS ARS 0000950170-24-045298 001-41854 24852726 34 2385065
2024-04-18 DEF 14A DEF 14A 0000950170-24-045297 001-41854 24852725 34 2482621
2024-03-25 4 xslF345X05/form4.xml 0000929638-24-001102 5095
2024-03-20 4 xslF345X05/form4.xml 0000929638-24-001069 6688
2024-03-19 4 xslF345X05/form4.xml 0000929638-24-001049 5130
2024-03-12 424B3 424B3 0000950170-24-029572 333-275700 24739903 33 1258221
2024-03-11 10-Q 10-Q 0000950170-24-029413 001-41854 24739074 34 8669711 1 1
2024-03-11 8-K 8-K 2.02,9.01 0000950170-24-029396 001-41854 24738999 34 310728 1 1
2024-03-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-03-05 16:00:00 9999999995-24-000603 333-275700 24724272 33 1753
2024-03-05 424B3 424B3 0001193125-24-059432 333-275700 24722572 33 13721679
2024-03-04 CORRESP filename1.htm 0001193125-24-057765 18269
2024-02-27 S-8 S-8 0001193125-24-046586 333-277378 24681530 33 116068
2024-02-27 S-1/A S-1/A 0001193125-24-046578 333-275700 24681511 33 31758145 1 1
2024-02-26 CORRESP filename1.htm 0001193125-24-046585 15775
2024-02-26 SC 13G SC 13G 0001104659-24-027508 005-94211 24678915 34 172273
2024-02-23 SC 13G deeptrack-engn021424.htm 0001172661-24-001669 005-94211 24672191 34 102979
2024-02-23 SC 13G SC 13G 0001104659-24-026940 005-94211 24669716 34 74162
2024-02-22 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-000530 005-94211 24665625 34 280783
2024-02-21 4 xslF345X05/form4.xml 0000905148-24-000774 11840
2024-02-21 4 xslF345X05/form4.xml 0000905148-24-000773 12529
2024-02-21 SC 13D/A SC 13D/A 0001140361-24-008788 005-94211 24659646 34 701290
2024-02-14 SC 13G SC 13G 0001140361-24-008104 005-94211 24641752 34 49161
2024-02-14 SC 13G SC 13G 0001193125-24-036704 005-94211 24641399 34 125743
2024-02-14 8-K 8-K 1.01,3.02,5.02,7.01,9.01 0001193125-24-035074 001-41854 24632302 34 14963526 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-035047 005-94211 24632268 34 52731
2024-02-02 3 xslF345X02/form3.xml 0000929638-24-000357 8265
2024-01-29 10-K 10-K 0000950170-24-008125 001-41854 24570085 34 33597691 1 1
2024-01-29 8-K 8-K 2.02,9.01 0000950170-24-008123 001-41854 24570076 34 300557 1 1
2024-01-11 CORRESP filename1.htm 0001193125-24-006430 15672
2023-12-28 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-23-305161 001-41854 231522794 34 794279 1 1
2023-12-26 UPLOAD filename1.pdf 0000000000-23-014102 333-275700 44815
2023-12-21 8-K CURRENT REPORT 5.02,7.01,9.01 0000929638-23-003464 001-41854 231502371 34 229005 1 1
2023-12-19 3 xslF345X02/form3.xml 0000929638-23-003436 8112
2023-12-15 CORRESP filename1.htm 0001193125-23-296750 23413
2023-12-15 S-1/A S-1/A 0001193125-23-296741 333-275700 231491074 33 25603967 1 1
2023-12-13 8-K CURRENT REPORT 5.02,9.01 0000929638-23-003423 001-41854 231484019 34 333687 1 1
2023-12-08 UPLOAD filename1.pdf 0000000000-23-013437 333-275700 52030
2023-12-04 4 xslF345X05/form4.xml 0000929638-23-003341 5023
2023-12-04 4 xslF345X05/form4.xml 0000929638-23-003339 4968
2023-11-29 3 xslF345X02/form3.xml 0000929638-23-003310 2705
2023-11-29 8-K CURRENT REPORT 5.02,7.01,9.01 0000929638-23-003305 001-41854 231453010 34 387464 1 1
2023-11-22 S-1 S-1 0001193125-23-281677 333-275700 231429764 33 27011351 1 1
2023-11-13 3 OWNERSHIP DOCUMENT 0000921895-23-002575 27160
2023-11-13 SC 13G THE SCHEDULE 13G 0000921895-23-002574 005-94211 231399615 34 288347
2023-11-13 SC 13G SC 13G 0001193125-23-275986 005-94211 231398404 34 58435
2023-11-13 3 3 0000950170-23-062887 7222
2023-11-13 SC 13D SC 13D 0001193125-23-275936 005-94211 231398199 34 605362
2023-11-09 8-K CURRENT REPORT 5.02,9.01 0000929638-23-003066 001-41854 231393901 34 592585 1 1
2023-11-08 SC 13D SC 13D 0001140361-23-051933 005-94211 231385402 34 774156
2023-11-07 3 xslF345X02/form3.xml 0000905148-23-001334 24044
2023-11-07 SC 13G SCHEDULE 13G 0000950142-23-002732 005-94211 231384072 34 47603
2023-11-02 4 FORM 4 0000950103-23-015956 21555
2023-11-02 3 xslF345X02/dp202276_3-forbion.xml 0000950103-23-015955 14147
2023-11-02 4 xslF345X05/form4.xml 0000929638-23-002991 9502
2023-11-02 4 xslF345X05/form4.xml 0000929638-23-002990 24949
2023-11-02 4 xslF345X05/form4.xml 0000929638-23-002989 16356
2023-11-02 4 xslF345X05/form4.xml 0000929638-23-002988 9492
2023-11-02 4 xslF345X05/form4.xml 0000929638-23-002987 24640
2023-11-02 4 xslF345X05/form4.xml 0000929638-23-002986 36504
2023-10-31 3 OWNERSHIP DOCUMENT 0000950142-23-002706 8669
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002953 2772
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002952 2728
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002951 2745
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002950 2757
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002949 8221
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002948 8090
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002947 8114
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002946 8174
2023-10-31 3 xslF345X02/form3.xml 0000929638-23-002945 8762
2023-10-31 8-K 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,9.01 0001193125-23-267243 001-41854 231365236 34 1386812 1 1
2023-10-31 CERT 8A_Cert_ENGN.pdf 0001354457-23-000796 001-41854 231362872 34 212167
2023-10-31 8-A12B 8-A12B 0001193125-23-266836 001-41854 231362536 34 14175
2023-10-24 425 425 0001193125-23-261767 333-273851 231343403 34 30104
2023-10-02 424B3 424B3 0001193125-23-247752 333-273851 231297251 33 12673229
2023-09-29 SEC STAFF LETTER filename1.pdf 9999999997-23-004387 62868
2023-09-29 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-09-29 10:00:00 9999999995-23-002876 333-273851 231297505 33 1709
2023-09-28 CORRESP filename1.htm 0001193125-23-244614 7522
2023-09-26 S-4/A S-4/A 0001193125-23-241581 333-273851 231277005 33 12577602
2023-09-25 CORRESP filename1.htm 0001193125-23-241584 27462
2023-09-15 425 425 0001193125-23-235927 333-273851 231257317 34 17100261
2023-09-11 UPLOAD filename1.pdf 0000000000-23-010029 46013
2023-08-30 S-4/A S-4/A 0001193125-23-224097 333-273851 231223543 33 12621361
2023-08-29 CORRESP filename1.htm 0001193125-23-224107 22562
2023-08-22 SEC STAFF LETTER filename1.pdf 9999999997-23-003977 65154
2023-08-22 UPLOAD filename1.pdf 0000000000-23-009188 49385
2023-08-09 CORRESP filename1.htm 0001193125-23-207515 111731
2023-08-09 S-4 S-4 0001193125-23-207502 333-273851 231156220 33 18089198
2023-07-12 UPLOAD filename1.pdf 0000000000-23-007460 93977
2023-06-14 DRS filename1.htm 0000950123-23-005719 377-06746 231014945 33 11224576

Latest XBRL company facts

One latest value per concept from companyfacts (209 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 67.02M 2026-09-02 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
dei EntityPublicFloat Entity Public Float USD 154.18M 2025-04-30 2025 FY 10-K/A 2026-02-19 0001193125-26-059409
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.54M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.36M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 19,000 2025-10-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 22.22M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 989,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.63M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.35M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 64.13M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 7.81M 2026-05-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 411,000 2025-11-01 2026-01-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.76M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AmountOfDilutiveSecuritiesESOPConvertiblePreferredStock Dilutive Securities, Effect on Basic Earnings Per Share, ESOP Convertible Preferred Stock USD 4.82M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 21.46M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 147,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap Assets Assets USD 288.32M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AssetsCurrent Assets, Current USD 277.90M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 163,000 2025-10-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 35,000 2025-10-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 185.49M 2025-10-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 185.62M 2025-10-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 332,000 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap Cash Cash USD 81.50M 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 41.02M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 81.52M 2023-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 41.02M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -9.13M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2023-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.5 2024-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 8.55M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 27.94M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 67.01M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 67.01M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CommonStockValue Common Stock, Value, Issued USD 632.02M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -92.94M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ConvertibleDebt Convertible Debt USD 0 2023-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 0 2024-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap CostMaintenance Cost, Maintenance USD 50,000 2020-04-10 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -19,000 2023-11-01 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -19,000 2023-11-01 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 8.00M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 1.90M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Security 1 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 136.10M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Security 52 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 0 2023-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.07M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 285,000 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 82.49M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 10.02M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 74,000 2022-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 61.13M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1,000 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 270,000 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 2.69M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 894,000 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 924,000 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 80.43M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 65,000 2022-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap Depreciation Depreciation USD 547,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 500,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.34 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.34 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.265 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.268 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.006 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.003 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.007 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.006 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.10M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 29.70M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -10.85M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2023-11-01 2024-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2023-11-01 2024-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2023-11-01 2024-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -10,849 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 11,456 2022-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -489,000 2022-11-01 2023-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 100,000 2022-11-01 2023-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -11,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -22,000 2023-11-01 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -488,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32.63M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -103.73M 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -92.48M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -13.57M 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -4.15M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 6.94M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -537,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3.91M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap InterestExpense Interest Expense USD 1.29M 2023-11-01 2024-04-30 2024 Q2 10-Q 2024-06-14 0000950170-24-073330
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 2.32M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.59M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.80M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LeaseCost Lease, Cost USD 1.86M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 11.45M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.08M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.39M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.50M 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.50M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.46M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.41M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 623,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3.54M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap Liabilities Liabilities USD 58.03M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 288.32M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 1.13M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap LiabilitiesCurrent Liabilities, Current USD 27.21M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 25.16M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 225.29M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 141.76M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -72.54M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -78.35M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -92.48M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -92.48M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -92.48M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.69M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NotesPayableCurrent Notes Payable, Current USD 199,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingExpenses Operating Expenses USD 97.17M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -97.17M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.86M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.92M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.25M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 5.67M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OperatingLeasePayments Operating Lease, Payments USD 620,000 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.88M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 665,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.39M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -463,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -1.17M 2021-11-01 2022-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -210,000 2026-05-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 10.97M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -309,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 545,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PaymentsOfDividends Payments of Dividends USD 0 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 9.45M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 125.03M 2023-11-01 2024-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 261.78M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 251,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2024-07-31 2024 Q3 10-Q 2024-09-10 0000950170-24-105180
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-07-31 2024 Q3 10-Q 2024-09-10 0000950170-24-105180
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-07-31 2024 Q3 10-Q 2024-09-10 0000950170-24-105180
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.53M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 38.00M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 126.25M 2025-11-01 2026-01-31 2026 Q1 10-Q 2026-03-09 0001193125-26-097541
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 25.00M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 260.15M 2023-11-01 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 23.25M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 56.89M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 189.49M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 303,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 5.98M 2023-11-01 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -92.48M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.79M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.16M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 4.82M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2024-05-01 2024-07-31 2024 Q3 10-Q 2024-09-10 0000950170-24-105180
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 3.18M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.01M 2021-11-01 2022-10-31 2023 FY 10-K 2024-01-29 0000950170-24-008125
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 64.54M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap RestrictedInvestments Restricted Investments USD 79,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -464.51M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 6.35M 2024-11-01 2025-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD -4.69M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14.76M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.05M 2024-01-31 2024 Q1 10-Q 2024-03-11 0000950170-24-029413
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.88M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 8 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.84M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.55 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 7.02M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 6.07 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 624,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.55M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.47 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 5.53M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 532,000 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 252,121 2023-07-07 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.99 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 794,643 2023-07-07 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.12 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 8.14 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap SharePrice Share Price USD/shares 18 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 411,000 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 230.29M 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.18 2021-06-30 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 142,469 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 53.12M 2022-11-01 2023-10-31 2024 FY 10-K 2024-12-19 0000950170-24-138472
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 118.27M 2025-11-01 2026-01-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 23,000 2026-05-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 0 2024-11-01 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2025-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap VariableLeaseCost Variable Lease, Cost USD 24,000 2023-11-01 2024-10-31 2025 FY 10-K 2025-12-22 0001193125-25-328743
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 68.90M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 68.90M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-08 0001193125-26-384383

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →